Solid-phase extraction method with high-performance liquid chromatography and electrochemical detection for the quantitative analysis of oxycodone in human plasma.
A sensitive and reproducible solid-phase extraction (SPE) method for the quantification of oxycodone in human plasma was developed. Varian Certify SPE cartridges containing both C8 and benzoic acid functional groups were the most suitable for the extraction of oxycodone and codeine (internal standard), with consistently high (> or =80%) and reproducible recoveries. The elution mobile phase consisted of 1.2 ml of butyl chloride-isopropanol (80:20, v/v) containing 2% ammonia. The quantification limit for oxycodone was 5.3 pmol on-column. Within-day and inter-day coefficients of variation were 1.2% and 6.8% respectively for 284 nM oxycodone and 9.5% and 6.2% respectively for 28.4 nM oxycodone using 0.5-ml plasma aliquots.
Wright
A W
AW
School of Pharmacy, The University of Queensland, St. Lucia, Brisbane, Australia.
Lawrence
J A
JA
Iu
M
M
Cramond
T
T
Smith
M T
MT
D000701:Analgesics, Opioid / Q000097:blood*; D002648:Child; D002851:Chromatography, High Pressure Liquid; D004563:Electrochemistry; D006801:Humans; D010098:Oxycodone / Q000097:blood*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D000701:Analgesics, Opioid; D010098:Oxycodone